Loan Capital Changement Date
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 17.18M 17.43M 2023-12
Alnylam Pharmaceuticals USD 1.02B 967K 2023-12
Arrowhead Research USD 263.06M 263.06M 2023-06
AstraZeneca USD 22.97B 2.08B 2023-09
Bluebird Bio USD 0 0 2022-06
Bristol-Myers Squibb USD 32.14B 2.52B 2023-09
Eli Lilly USD 17.92B 956.9M 2023-09
Enanta Pharmaceuticals USD 1.42M 0 2023-09
Esperion Therapeutics USD 261.16M 427K 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Heron Therapeutics USD 149.44M 52K 2023-09
Insmed USD 1.18B 7.11M 2023-12
J&J USD 26.05B 7.85B 2023-09
Ligand Pharmaceuticals USD 176.54M 144.18M 2022-03
Merck USD 33.97B 100M 2023-09
Moderna USD 575M 0 2023-12
Pfizer USD 61.05B 308M 2023-09
PTC Therapeutics USD 1.92B 673.35M 2023-12
Sangamo BioSciences USD 0 0 2022-06
Takeda JPY 4.4T 74.11B 2023-09
Teva Pharmaceutical Industries USD 18.5B 203M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Veracyte USD 100K 100K 2023-09



Vanda Pharmaceuticals Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2024.